BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Brise Pharmaceuticals Raises nearly $20M in Series Pre-A and Pre-A+ Financing

  Brise Pharmaceuticals Co., LTD., a pioneering company specializing in innovative treatments for acute and chronic pain, has recently completed Pre-A and Pre-A+ financing with a total of approximately $20 million.

  April 22, 2024

   · 

  1 min read
• Deals

  Nanox Files 2023 Annual Report on Form 20-F

  NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (“SEC”) on April 22, 2024.

  April 22, 2024

   · 

  1 min read
• TrialAssure Joins NVIDIA Inception

  April 22, 2024

   · 

  2 min read
• Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to Organs and Tumors

  Vect-Horus announced the publication of a paper in the open-access scientific journal Pharmaceutics Vol 26.

  April 22, 2024

   · 

  2 min read
• Business

  PharmaLogic announces opening of new state-of-the-art radiopharmaceutical production facility in Cincinnati

  PharmaLogic Holdings Corp. announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio.

  April 22, 2024

   · 

  2 min read
• DNA Nanotechnology Market Expected to Grow at a CAGR of 24.67% from 2024 to 2031

  Global DNA Nanotechnology Market is valued at US$ 4.34 Bn in 2023, and it is expected to reach US$ 24.29 Bn by 2031, with a CAGR of 24.67% during the forecast period of 2024-2031.

  April 22, 2024

   · 

  4 min read
• Exosome Research Market Will Grow at a CAGR of 16.26% 2024-2031

  Global Exosome Research Market is valued at US$ 172.30 Mn in 2023, and it is expected to reach US$ 570.70 Mn by 2031, with a CAGR of 16.26% during the forecast period of 2024-2031.

  April 22, 2024

   · 

  4 min read
• Lone Star Bio

  CNS Pharmaceuticals to Participate in the Virtual Investor Lunch Break: The CNSP Opportunity

  CNS Pharmaceuticals, Inc. today announced that John Climaco, Chief Executive Officer of CNS Pharmaceuticals will present at the Virtual Investor Lunch Break: The CNSP Opportunity event on Tuesday, April 23, 2024 at 12:00 PM ET.

  April 22, 2024

   · 

  1 min read
• BoomRay’s Radioactive Diagnostic New Drug [18F]BF3-BPA Injection Completes First Subject Enrollment in Phase I Clinical Trial

  BoomRay Pharmaceutical Co., Ltd. (“BoomRay”) announced that the phase I clinical trial of its positron emission tomography (PET) tracer [18F]BF3-BPA injection for the diagnosis of primary and metastatic brain tumors has completed the enrollment of the first subject.

  April 22, 2024

   · 

  2 min read
• Pancreatic Cancer Market Size to Rise at USD 7.4 Billion by 2032

  The pancreatic cancer market size grew to USD 2.05 billion in 2022 and is estimated to hit approximately USD 7.4 billion by 2032, with a CAGR of 13.7% for the period of 2023 – 2032.

  April 22, 2024

   · 

  12 min read